Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. - Wikidata - awgldk - TriplyDB

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

http://www.wikidata.org/entity/Q45126827

about

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein Detection of antibodies to hepatitis C virus in U.S. blood donors Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions.Serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (gamma-GT) activities in north London blood donors Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors The hazards of blood transfusion in historical perspective.Hepatitis B and hepatitis delta virus infection in South America.Perioperative haemotherapy: II. Risks and complications of blood transfusion.Occult hepatitis B virus infection and blood transfusion Occult hepatitis B virus infection: implications in transfusion.Hepatitis C infection in hemodialysis units Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.A study-screening of blood donors for blood transmissible diseases The infectious complications of blood transfusion.Prevalence of Hepatitis C virus antibody in patients with sexually transmitted diseases attending a Harrisburg, PA, STD clinic.Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc.Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen.Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen.The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis.Blood transfusion and hepatitis: still a threat?Risk factors associated with hepatitis B or C markers or elevated alanine aminotransferase level among blood donors on a tropical island: the Guadeloupe experience.Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.Stability of the recombinant hepatitis B core antigen.Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen.Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay.Blood system changes since recognition of transfusion-associated AIDS.Assessment of screening tests for transfusion-associated non-A non-B hepatitis.Viral contamination of blood components and approaches for reduction of infectivity.Transfusion reactions: the changing priorities.Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing Viral risks associated with blood transfusion.Posttransfusion hepatitis in Japan.The road not taken or how I learned to love the liver: a personal perspective on hepatitis history.Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.Seropositivity to hepatitis C virus in Saudi haemodialysis patients.Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis. The EATHIS Eco Research Group. European Acute Transfusion Hepatitis Interferon Study.Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.

P2860

Q27487933-A5B3667A-CE71-4275-A39C-3B9F802CC0DE Q27488778-C643002A-E34C-4AFD-BFC3-13BBFDA23701 Q29615898-4923A5A5-7BFD-4063-9D36-DFB36EAC511B Q33339419-FF5DF94E-3877-49FE-9CF1-76A2A7D011B5 Q33447492-D3CB7D8B-C3AA-4914-9009-1771505A620E Q33838369-96A185F8-5771-49C5-970A-D4DB6D61D164 Q33876809-5FCF83D3-4EDF-48CF-9AC0-33308EC50113 Q34231829-94544B7D-06E8-4618-9DBD-301D71E07910 Q34442036-F99C67A7-63A8-4CB7-9E93-576063D3B2AA Q35188010-1592A4CC-E4DE-4286-A104-32CB9EFE4D4A Q35237335-DD57EB10-9D6A-4FB0-88B1-54D49A2A6A46 Q35691937-FCFC0F42-D4E9-4826-BB95-BFB7322B66A4 Q35948669-6430A3DB-20D8-49FA-95C5-B3BD04377E7D Q36221675-EE7EE1E5-BB58-4EEB-95B2-DAD572F1801B Q36263192-E7509427-05F0-4C5A-BD85-060340D7FA55 Q36414404-8BE30D97-B5ED-42D6-A7FB-B98A829409D6 Q36624509-270720A0-3C82-43E0-B3B3-82E2430BAD5B Q36817997-5D33C11A-A8C9-44C2-8AD9-477FEAA7E4AA Q37172463-2F86DC17-B77A-46AE-9497-2DB7E69DB639 Q37180199-FE3FC38E-25AA-4605-B4C3-0740477EE6F2 Q37232304-891F5EAA-77C9-415E-A27D-4A7BC2BFA5D3 Q37576273-DF1A017B-85A9-465E-86DB-4158456B6835 Q38602709-C7D91F0A-0229-4C7E-B979-E52B0F9D652B Q39003719-E448CCC9-8C7F-4023-8C43-100AA4DB6D72 Q40108907-D6F37426-7025-4ADC-AF40-3823996EE40B Q40186695-47B80D8A-C403-43BA-87DD-D0641E30FFD0 Q40211462-55E898C1-0E33-4BA7-B3B6-8DB8392E6FD9 Q40211473-60E5F9AA-2085-4583-95BA-31CCFDBAD648 Q40234714-F3F0E51C-C2F6-4D64-8AC9-9AFA1875107F Q40385747-69CE4AF5-26AF-43AA-8CFA-BA7D015459A4 Q40505254-632E8A07-31E2-4C7C-9FE6-8B1577AF9D02 Q40505263-EAF5E85B-BF4D-40DF-B170-3D4FE079D955 Q41111337-9CF5089F-2560-4297-AA83-AF02C77E7620 Q41391574-D93C7A0C-2AD0-48BA-81AC-7FB16D2AA664 Q42017672-30EC61CC-96DB-4BC5-BED7-EF5E320D864C Q42262653-DD0F38ED-1E5C-4AE5-A1C3-D0EE7DAA5A1C Q42981526-EA6DEAF6-EB95-43EF-A1DA-AC17FCE3C42C Q42981867-5C36617E-E2E9-4FEC-A599-E6E73F2F6635 Q42982589-6342BF54-F1F4-4B3C-BE30-10D81DF75B82 Q42984286-9DF44FC7-D645-42F4-A308-55C169D14E68

P2860

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

http://www.wikidata.org/entity/Q45126827

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年学术文章

@wuu

1986年学术文章

@zh

1986年学术文章

@zh-cn

1986年学术文章

@zh-hans

1986年学术文章

@zh-my

1986年学术文章

@zh-sg

1986年學術文章

@yue

1986年學術文章

@zh-hant

name

Antibody to hepatitis B core a ...... titis agents in donated blood.

@en

Antibody to hepatitis B core a ...... titis agents in donated blood.

@nl

type

label

Antibody to hepatitis B core a ...... titis agents in donated blood.

@en

Antibody to hepatitis B core a ...... titis agents in donated blood.

@nl

prefLabel

Antibody to hepatitis B core a ...... titis agents in donated blood.

@en

Antibody to hepatitis B core a ...... titis agents in donated blood.

@nl

P1433

Q45126827-D2415883-97A4-4D60-9166-1F702F68DE66

P1476

Q45126827-98833155-81F8-47C9-8014-7BD9E6B93220

P2093

Q45126827-207D82EB-9C51-40D2-8CDC-8119C2A95A43

Q45126827-2672F28E-9260-4837-9D1D-DF8C5652F03A

Q45126827-4095B232-E3CA-41E0-888C-4019EE26B9B9

Q45126827-505383A5-5068-4366-B6DC-72BC94CA5118

Q45126827-59EB7A82-25DD-441D-8851-F359C549CD05

Q45126827-73F2EAB4-6949-41E9-83A5-E5F6B3DEBEF2

Q45126827-790B8C62-A782-4975-B79C-1AB2470980FD

Q45126827-82EB3A86-E759-4C44-8CC5-50029237B790

Q45126827-A9171CD6-B58C-401C-9301-D1ECF0783B12

Q45126827-F983988F-3BE2-485D-AA08-F54299B43083

P304

Q45126827-20622A92-A887-4745-8E3C-A60F08A22B5A

P31

Q45126827-5895E54F-0841-4C15-90BE-F609C009E7BF

P356

Q45126827-895117AE-889D-4EAD-AED3-7D6F4F34166E

P407

Q45126827-88A88617-FA72-40C1-915D-A264529B9EA7

P433

Q45126827-6139CCE3-8CFA-4957-930A-300DB5A5AA6A

P478

Q45126827-814277D7-B5D0-43B0-A977-6BE0D641FCDE

P577

Q45126827-00574FD2-99B4-4ACC-89F1-E341CC87E300

P698

Q45126827-0C4B0679-0843-4E89-A1CC-26517DE9B6E2

P921

Q45126827-84B06F78-A3D4-4B32-98A1-1EC5E07DC29F

P356

0003-4819-104-4-488

P1433

Annals of Internal Medicine

P1476

Antibody to hepatitis B core a ...... titis agents in donated blood.

@en

P2093

Alling DW

http://www.w3.org/2001/XMLSchema#string

Alter HJ

http://www.w3.org/2001/XMLSchema#string

Holland PV

http://www.w3.org/2001/XMLSchema#string

Hudson LM

http://www.w3.org/2001/XMLSchema#string

Koziol DE

http://www.w3.org/2001/XMLSchema#string

Krakauer H

http://www.w3.org/2001/XMLSchema#string

Melpolder JC

http://www.w3.org/2001/XMLSchema#string

Purcell RH

http://www.w3.org/2001/XMLSchema#string

Shoup FJ

http://www.w3.org/2001/XMLSchema#string

Solomon RE

http://www.w3.org/2001/XMLSchema#string

P304

488-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-104-4-488

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1986-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3006567

http://www.w3.org/2001/XMLSchema#string

P921